Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Persaud, C.
Right arrow Articles by Jackson, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Persaud, C.
Right arrow Articles by Jackson, A. A.

Urinary Excretion of 5-L-Oxoproline (Pyroglutamic Acid) Is Increased during Recovery from Severe Childhood Malnutrition1,2, and Responds to Supplemental Glycine

Chandarika Persaud, Terrence Forrester* and Alan A. Jackson3

Institute of Human Nutrition, University of Southampton, Bassett Crescent East Southampton SO16 7PX, United Kingdom * Tropical Metabolism Research Unit, University of the West Indies, Mona, Kingston 7, Jamaica

We hypothesized that a limitation in the endogenous formation of glycine might constrain catch-up growth during recovery from severe childhood malnutrition. The urinary excretion of 5-L-oxoproline is increased when the glycine available for glutathione synthesis is limited. Urinary excretion of 5-L-oxoproline was measured throughout recovery in 12 children (aged 16 ± 6 mo) with severe malnutrition. Urinary 5-L-oxoproline was similar at admission and after recovery, but was increased significantly during rapid catch-up growth. There was a significant relationship between the rate of weight gain and 5-L-oxoproline excretion in urine. In nine children (aged 15 ± 5 mo), the effect of oral supplementation with glycine, [1.7 mmol/(kg·d) for 48 h] during rapid catch-up growth on 5-L-oxoprolinuria and blood glutathione concentration was determined. In seven of the nine children weight gain was less than 17 g/(kg·d) and following oral glycine supplements 5-L-oxoproline excretion was reduced up to 64% and blood glutathione concentration increased up to 100%. In the two children who were gaining weight at a rate >17 g/(kg·d), glycine supplementation was associated with a further increase in 5-L-oxoproline excretion and a decrease in blood glutathione. If 5-L-oxoproline is an index of the relative availability of glycine, then the data indicate that glycine may be limiting during rapid catch-up growth. This would have important implications for repletion of muscle and gain in height.


KEY WORDS: • catch-up growth • glutathione • human protein requirements • amino acids • nitrogen

1 Supported in part by the Nestlé Nutrition Research Grant Fund

2 The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.

3 To whom correspondence should be addressed.

Manuscript received 26 February 1996. Revision accepted 23 July 1996.




This article has been cited by other articles:


Home page
Nutr Clin PractHome page
V. H. Castellanos, M. D. Litchford, and W. W. Campbell
Modular Protein Supplements and Their Application to Long-Term Care
Nutr Clin Pract, October 1, 2006; 21(5): 485 - 504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
F. Jahoor, A. Badaloo, M. Reid, and T. Forrester
Glycine production in severe childhood undernutrition
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 143 - 149.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. Z. Fenves, H. M. Kirkpatrick III, V. V. Patel, L. Sweetman, and M. Emmett
Increased Anion Gap Metabolic Acidosis as a Result of 5-Oxoproline (Pyroglutamic Acid): A Role for Acetaminophen
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 441 - 447.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. L. Foot, J. F. Fraser, and D. V. Mullany
Pyroglutamic acidosis in a renal transplant patient
Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2836 - 2838.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1996 by American Society for Nutrition